Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 133.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.82m
  • Volume: 3,012
  • Market Cap: £113.23m
  • RiskGrade: 196
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.59% above the market average73.59% above the market average73.59% above the market average73.59% above the market average73.59% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
15.66% above the market average15.66% above the market average15.66% above the market average15.66% above the market average15.66% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Book Ratio
56.4% below the market average56.4% below the market average56.4% below the market average56.4% below the market average56.4% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
86.09% above the market average86.09% above the market average86.09% above the market average86.09% above the market average86.09% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Price Chg 3m
23.71% above the market average23.71% above the market average23.71% above the market average23.71% above the market average23.71% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
85.23% above the market average85.23% above the market average85.23% above the market average85.23% above the market average85.23% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Momentum 20
75.48% above the market average75.48% above the market average75.48% above the market average75.48% above the market average75.48% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
52.42% below the market average52.42% below the market average52.42% below the market average52.42% below the market average52.42% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.1% below the market average68.1% below the market average68.1% below the market average68.1% below the market average68.1% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
12.71% below the market average12.71% below the market average12.71% below the market average12.71% below the market average12.71% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Operating Profit Loss
59.85% below the market average59.85% below the market average59.85% below the market average59.85% below the market average59.85% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.13% above the market average3.13% above the market average3.13% above the market average3.13% above the market average3.13% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Cash
14.57% above the market average14.57% above the market average14.57% above the market average14.57% above the market average14.57% above the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
20.40% above the market average20.40% above the market average20.40% above the market average20.40% above the market average20.40% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Buys 1y
70% below the market average70% below the market average70% below the market average70% below the market average70% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 133.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 150.00
52 Week Low 108.00
Volume 3,012
Shares Issued 84.82m
Market Cap £113.23m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.04% below the market average32.04% below the market average32.04% below the market average32.04% below the market average32.04% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Price Trend
14.50% above the market average14.50% above the market average14.50% above the market average14.50% above the market average14.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
47.72% above the market average47.72% above the market average47.72% above the market average47.72% above the market average47.72% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
13:15 1,544 @ 132.77p
11:51 500 @ 133.85p
10:38 750 @ 132.75p
08:57 69 @ 135.00p
08:57 35 @ 135.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page